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The current anti-TB drugs have had success in decreasing the number of deaths caused by 
TB, however, this success is limited by the emergence of drug resistant TB strains. Therefore, 
a novel TB therapy that limits the development of resistance has become necessary in an 
attempt to effectively control TB. The anti-TB drugs directly target mycobacterial enzymes, 
and potentiate the development of this resistance, and have therefore provided the rationale 
for this study. The aim was therefore to identify host macrophage genes that affect M. tb 
intracellular survival. The proposed alternative anti-TB therapy potentially involves the 
application of RNA interference (RNAi) and RNA activation (RNAa) biological processes 
that will target host genes, thereby inducing an indirect bactericidal effect. We hypothesized 
that macrophage genes that are differentially expressed by pathogenic and non-pathogenic 
mycobacterial species may be important in the regulation of M. tb intracellular survival. The 
lipid-rich mycobacterial cell wall is implicated in the excessive clumping of the 
mycobacterial cells in liquid culture. In order to minimize this, Tween 80 detergent was 
supplemented (mycobacteria
T
). However, due to substantial evidence emphasising the 
detrimental effects of Tween 80 on the mycobacterial cell wall, mycobacteria were also 
cultured without Tween 80 (mycobacteria
NT
), in order to investigate if the perturbed 
mycobacterial cell wall induced by Tween 80 affects the transcriptional response of 
macrophages. We endeavoured to develop a new method to culture mycobacteria without 
Tween 80 that will still generate single cells. We further hypothesized that the macrophage 
gene expression profile induced by mycobateria
NT





Differentiated THP-1 (dTHP-1) cells were infected with pathogenic and non-pathogenic 
mycobacteria (for 3 h, 24 h and 48 h with M. tb and M. bovis BCG, and 3 h and 8 h with M. 
smegmatis) cultured in the presence or absence of Tween 80. The expression of 12 
macrophage genes, selected based on their involvement in the phagocytic pathway and 
autophagy, as well as their general involvement in the immune response, was determined by 
qRT-PCR and further analysed on the REST programme. The expression of each target gene 
was normalised relative to the expression of the reference gene (Beta actin).  
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We observed that out of the 12 genes, TLR7 and VAMP7 were consistently downregulated in 
dTHP-1 cells infected with M. tb
NT
 and upregulated in dTHP-1 cells infected with M. 
smegmatis
NT
. Their response to M. bovis BCG was inconsistent and not significantly 
different, and therefore could not be interpreted. Furthermore, CCL1 was upregulated by all 
the mycobacterial species. However, its expression was more pronounced in response to 
mycobacteria
NT




Differential gene expression of TLR7 and VAMP7 in response to pathogenic and non-
pathogenic mycobacteria
NT
 suggests that these 2 genes may be potential targets for RNAa-
based anti-TB therapy, even though we could not conclude whether their response was 
specific to macrophages. In addition, the observed difference in the expression of CCL1 
induced by mycobacteria
NT
, compared to mycobacteria
T
 suggests that the perturbation caused 
by Tween 80 on the mycobacterial cell wall most likely affected the response of macrophages 
to infection with mycobacteria. Furthermore, this study has demonstrated a feasible method 
by filtration to generate single cells from mycobacteria
NT
, which should be considered for 



















Die huidige anti-tuberkulose middels se sukses lê daarin dat dit die aantal sterftes verminder 
maar hierdie sukses word weer beperk met die ontstaan van middel-weerstandige M.tb 
stamme. Daarom is nuwe middels nodig wat die ontwikkeling van middel-weerstandigheid 
beperk in ŉ poging om effektiewe TB behandeling te bewerkstellig. Anti-tuberkulose middels 
teiken hoofsaaklik mycobakteriële ensiemsisteme en ontlok sodoende weerstandigheid in 
M.tb stamme en dit vorm die rasionale vir hierdie studie. Die doel was om gasheer makrofaag 
gene te identifiseer wat M.tb oorlewing intrasellulêr bewerkstellig. Die voorgestelde 
alternatiewe anti-TB behandeling sal dan behels die toepassing van RNA intervensie (RNAi) 
en RNA aktivering (RNAa) tegnologie wat gasheer selgene teiken (inaktiveer) en sodoende ŉ 
bakterisidiese respons induseer. Die kanse is skraal dat mycobakterieë weerstandigheid sal 
kan ontwikkel onder hierdie omstandighede. Ons hipotetiseer dus dat makrofaag gene wat 
differensieel uitgedruk word deur patogeniese en nie-patologiese mycobakteriële spesies 
belangrik mag wees vir die oorlewing van M.tb intrasellulêr. Die lipiedryke selwand van 
mycobakterieë word geïmpliseer in die oormatige sameklomping van die bakterieë  in 
vloeistofkulture. Om hierdie effek te minimaliseer word Tween 80 normaalweg tot die 
medium gevoeg (mycobakterieë
T
). Maar weens genoegsame bewyse dat Tween-80 die 
selwand van bakterieë nadelig beïnvloed, is mycobakterieë ook in die afwesigheid van Tween 
80 gekultureer (mycobakterieë
NT
) om te bepaal of die nadelige effek van Tween 80 op die 
selwand die transkripsionele respons in makrofage beïnvloed post-infeksie. Dit was daarom 
ook ons doelstelling om ŉ nuwe tegniek te ontwikkel om mycobakterieë te kultureer in die 
afwesigheid van Tween 80 wat ook enkelselle sal genereer vir beter gekontroleerde 
makrofaag infeksie. Ons hipotetiseer ook verder dat makrofaag geenuitdrukking-profiele 
verskil afhangende of infeksie gedoen is met mycobakterieë wat in die afwesigheid of 
teenwoordigheid van Tween 80 gekultureer is. 
 
Gedifferensieerde THP-1 (dTHP-1) was geïnfekteer met patogeniese en nie-patogeniese 
mycobakterieë (vir 3 h, 24 h en 48 h met M.tb en M.bovis BCG, en 3 h en 8 h met 
M.smegmatis) gekultureer in die teenwoordigheid en afwesigheid van Tween 80. Die 
uitdrukking van 12 makrofaag gene, geselekteer op grond van hul betrokkenheid in die 
fagositose meganisme en in outofagie asook hul betrokkenheid in die immuunrespons, is 
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gekwantifiseer met qRT-PCR en daaropvolgens geanaliseer met die REST-program. Die 
uitdrukking van elke geen is genormaliseer relatief tot die uitdrukking van die 
verwysingsgeen (Beta actin). Daar is bevind dat van die 12 gene, TLR7 en VAMP7 
deurlopend afgereguleer was in dTHP-1 selle geïnfekteer met M.tb
NT
 en opgereguleer was in 
dTHP selle geïnfekteer met M.smegmatis
NT
. Selrespons met M.bovis BCG was onbeduidend 
en derhalwe kon geen gevolgtrekking hier gemaak word nie. Ook, CCL1 was opgereguleer 
met infeksie deur enige van die mycobakteriële spesies, maar CCL1 se uitdrukking was 
groter in respons tot mycobakterieë
NT





Differensiële geenuitdrukking van TLR7 en VAMP7 in respons tot patogeniese en nie-
patogeniese mycobakterieë
NT
 impliseer dat hierdie twee gene potensiële teikens kan wees vir 
RNAa-gebaseerde anti-TB behandeling, alhoewel ons nie kon beslis of hierdie respons 
spesifiek vir makrofage was nie. Ook, die verskille waargeneem in die uitdrukking van CCL1 
geïnduseer deur mycobakterieë
NT
, vergeleke met mycobakterieë
T
, impliseer dat die steuring 
in die selwand veroorsaak deur Tween 80, heelwaarskynlik die respons van die makrofaag 
beïnvloed het. Hierdie studie beskryf ook ŉ filtrasiemetode om enkele mycobakteriële selle te 
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Tuberculosis (TB) is a disease that is caused by infection with Mycobacterium tuberculosis 
(M. tb). It is transmitted among individuals via inhalation of aerosols produced through 
coughing and sneezing by infected individuals (Shakri et al., 2012). This bacterium enters the 
body via the respiratory route and binds to specific pattern recognition receptors (PRRs) on 
the surface of lung macrophages, allowing it to gain entry into macrophages,  where it resides 
and replicate (Aderem and Underhill, 1999; Chacón-Salinas et al., 2005; Ernst, 1998; Gordon 
and Read, 2002; Hu et al., 2000). PRRs are proteins involved in the recognition of molecular 
patterns that are associated with microbial pathogens, resulting in activation of the innate 
immune response for subsequent elimination of pathogens (Court et al., 2010; Schiller et al., 
2006). M. tb pathogenicity is due to its ability to withstand the hostile environment of 
macrophages (Schlesinger, 1996; Simeone et al., 2012) and its intracellular survival depends 
on the host factors (Jayaswal et al., 2010; Simeone et al., 2012). 
 
Despite the discovery of TB over a century ago, the availability of the Mycobacterium bovis 
Bacillus Calmette Guérin (M. bovis BCG) vaccine and anti-TB drugs, this disease is still one 
of the major daunting challenges in public health (Mehra et al., 2013; Simeone et al., 2012). 
The major factors interfering with TB control are mainly attributed to the inability of M. 
bovis BCG vaccine to provide permanent protection (Ottenhoff and Kaufmann, 2012), HIV 
co-infection (Matthews et al., 2012), the lengthy period of TB treatment regime 
(Padmapriyadarsini et al., 2011) as well as the emergence of drug resistant M. tb strains 
(Fakruddin, 2013; WHO; 2010; Yokobori et al., 2013). The latter is the primary basis of the 
existing battle in drug development research (Nguyen and Pieters, 2009). A novel approach 
that will limit the extent of resistance has therefore become necessary as an attempt to 
effectively control TB. 
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1.2 Macrophages as primary cells of M. tb infection 
Macrophages are phagocytes and primary cells of M. tb infection. Their ability to internalise, 
process and present antigens of invading pathogens for subsequent degradation makes them 
essential for host defence against infection (Harding and Boom, 2010; Martín-Orozco et al., 
2001; Wynn et al., 2013). Macrophages are involved in activation and maintenance of the 
immune responses (Chaurasiya and Srivastava, 2008; Giacomini et al., 2001; Wang et al., 
2003). Their primary role is to kill invading microbes; however, it has become clear that they 
are unable to permanently eliminate pathogenic mycobacteria such as M. tb (Giacomini et al., 
2011; Jayaswal et al., 2010; Reljic et al., 2010; Spira et al., 2003; Volpe et al., 2006). Their 
killing mechanisms are not entirely understood, however, they involve the fusion of 
phagosomes with lysosomes (Fairbairn et al., 2001; Zimmerli et al., 1996), production of 
proinflammatory cytokines including IL-12, IFN-γ and TNF-α (Giacomini et al., 2011, 2001; 
Reljic et al., 2010) and induction of apoptosis as means of protecting the host from 
intracellular pathogens (Behar et al., 2011).  
 
1.3 Macrophage - M. tb interaction 
Humans are equipped with an immune system (divided into innate and adaptive) that protects 
the body against diseases by eliminating invading pathogenic and non-pathogenic 
microorganisms (Nguyen and Pieters, 2009). Upon infection, macrophages become activated 
and produce cytokines as part of the immune response, and the fate of infection depends on 
the level of cytokines produced (Giacomini et al., 2011, 2001; Reljic et al., 2010).  
 
Cytokines are small protein molecules produced by the cells of the immune system, including 
macrophages. They are involved in cell signalling and have been classed as interleukins, 
interferons and chemokines based on the cell type they are secreted from; their presumed 
function and target (Berrington and Hawn, 2007; Giacomini et al., 2011, 2001). They bind to 
target cell receptors by autocrine, paracrine or endocrine action and stimulate signalling 
pathways to induce a biological response (Renner et al., 1996; Sherry and Cerami, 1988; 
Suga et al., 1993). They are implicated in the response of the immune system against M. tb 
infection and are divided into proinflammatory and immunosuppressive groups, based on 
their roles in the immune system. The role of proinflammatory cytokines is to orchestrate the 
immune response, in order to eliminate the invading pathogens. They are involved in the 
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regulation of innate and adaptive immunity (Giacomini et al., 2011, 2001). In contrast, 
immunosuppressive cytokines induced by M. tb, suppress the immune system by 
counteracting its antimicrobial responses, thereby leading to progression of infection to TB 
disease (Giacomini et al., 2011, 2001) 
 
Increased levels of proinflammatory cytokines result in either M. tb clearance or dormancy in 
the granuloma, whereas, an abundance of immunosuppressive cytokines lead to the 
progression of M. tb infection to TB disease (Figure 1.1) (Giacomini et al., 2011, 2001; Reljic 
et al., 2010; Rodríguez-Herrera and Jordán-Salivia, 1999). Furthermore, macrophages may 
induce a process known as autophagy, a defence mechanism initiated by the innate system for 
the elimination of intracellular pathogens (Gutierrez et al., 2004). Autophagy involves fusion 
of autophagosomes (organelles containing cytoplasmic material including phagosomes) with 
lysosomes, followed by lysosomal enzymatic digestion and elimination of the 
autophagosome contents (Gutierrez et al., 2004; Nakagawa et al., 2004).  
 
The initial interaction between macrophages and M. tb is important for the fate of the 
infection (Giacomini et al., 2011; Reljic et al., 2010). Depending on the bacterial load and the 
virulence of the infecting mycobacterial species, macrophages can either be activated to 
combat infection or induce apoptosis (Placido et al., 1997; Riendeau and Kornfeld, 2003; 
Rodríguez-Herrera and Jordán-Salivia, 1999). Apoptosis, which acts as a bridge between 
innate and adaptive immune responses, is the process of programmed cell death employed by 
host macrophages to destroy the invading intracellular pathogens, by eliminating the 
supportive environment for bacterial growth (Keane et al., 2000; Riendeau and Kornfeld, 
2003; Schaible et al., 2003). Infected macrophages attract immune cells that play a role in the 
immune response, to the site of infection (Ragno et al., 2001), resulting in formation of the 
granuloma. Granuloma is a hallmark of M. tb infection and it is an immune mechanism 
induced in attempt to contain the infecting pathogens that the immune system is unable to 
eliminate, such as M. tb (Hoshino et al., 2007; Tal et al., 2007; Thuong et al., 2008).  
 
In response, the parasitization of M. tb in macrophages lead to subversion of bactericidal 
processes of macrophages, such as phagosome maturation and phagosome-lysosome fusion 
(Clemens and Horwitz, 1995; Koul et al., 2004; Xu et al., 1994), secretion of 
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proinflammatory cytokines by enhancing the production of immunosuppressive cytokines 
such as IL-10 (Giacomini et al., 2011, 2001; Koul et al., 2004), presentation of antigens 
(Garcia-Romo et al., 2013; Harding and Boom, 2010; Koul et al., 2004), induction of the 
respiratory burst (rapid release of the reactive oxygen species) (Ehrt and Schnappinger, 2009) 
and induction of apoptosis (Divangahi et al., 2009; Koul et al., 2004; Riendeau and Kornfeld, 
2003; Spira et al., 2003). Although the molecular mechanisms by which M. tb disrupts 
phagosolysosome fusion are not entirely understood, Mehra et al (2013) reports that M. tb 
EsxH (effector molecule that has been linked to M. tb pathogenesis and survival within host 
cells) directly targets host Hrs (a component of the endosomal sorting complex required for 
transport (ESCRT)) to impair phagosomal traffick to lysosomes (Ilghari et al., 2011; A. 
Mehra et al., 2013). Another study, by Malik et al (2001) links the blockade of 
phagolysosome fusion to calcium deficiency in human macrophages. They report that this 
was due to M. tb inhibiting the activation of calcium-dependent effector proteins, calmodulin 
and calmodulin-dependent protein kinase II (Malik et al., 2001). In addition, it is known that 
subsequent to phagosome-lysosome fusion, mycobacteria remain in phagolysosomes for 
subsequent degradation by lysosomal enzymes (Figure 1.1). However, there has been 
accumulating evidence that M. tb can rupture the phagolysosomes, induce necrosis of 
infected macrophages and escape to multiply in new, non-fused phagosomes as well as in the 
cytoplasm. This phagolysosomal escape is associated with M. tb defence mechanism to evade 
the innate immunity (McDonough et al., 1993; Simeone et al., 2012). Furthermore, after 
several years of survival in a dormant state in granulomas, M. tb can reactivate and escape to 
spread to other tissues, resulting in infection progression to TB (Bold and Ernst, 2009; Silva 
Miranda et al., 2012). The interaction of macrophages with M. tb therefore represents a 
balance between macrophage antimicrobial activities and M. tb evasion mechanisms (Crevel 
et al., 2002). 
 
1.3.1 Primary PRRs for M. tb phagocytosis  
PRRs control the phagosomes/endosomes trafficking to lysosomes (Kang et al., 2005). M. tb 
is internalised by phagocytes such as macrophages via various surface receptors, of which 
complement and mannose receptors are primary for phagocytosis (Bermudez et al., 1999; 
Kang et al., 2005; Killick et al., 2013; Schlesinger, 1993; Spira et al., 2003). 
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CR3 is a heterodimer cell surface receptor consisting of CD11b and CD18 protein subunits 
(Ehlers, 2000; Melo et al., 2000; Velasco-Velázquez et al., 2003). CR3 plays a role in M. tb 
phagocytosis but not in the subsequent intracellular survival (Hu et al., 2000; Melo et al., 
2000). M. tb is able to bind CR3 opsonically as well as non-opsonically (Melo et al., 2000; 
Velasco-Velázquez et al., 2003). CR3 is essential in clearing mycobacterial infection; 
however it does not induce killing of M. tb when it is bound non-opsonically (Le Cabec et al., 
2000; Rooyakkers and Stokes, 2005). Moreover, several studies have reported that the entry 
of M. tb into macrophages through opsonic binding to CR3, results in the inhibition of IL-12 
production due to extracellular calcium influxes that result from receptor ligation as well as 
from the release of the reactive oxygen species (ROS) (Marth and Kelsall, 1997; Sutterwala 
et al., 1997). Ex vivo studies are in contrast with the in vivo, regarding the importance of CR3 
in M. tb phagocytosis. In an ex vivo study conducted in macrophages, it was observed that the 
ability of macrophages to bind and phagocytose M. tb was impaired when antibodies were 
produced against CR3, suggesting that CR3 is the predominant macrophage receptor for M. 
tb phagocytosis (Melo et al., 2000; Schlesinger et al., 1990; Spira et al., 2003; Velasco-
Velázquez et al., 2003). Conversely, in in vivo studies it was observed that M. tb was able to 
enter macrophages in the absence of CR3, suggesting that it uses alternative receptors. 
Furthermore, the course of M. tb infection was not altered in mice lacking CR3 (Hu et al., 
2000; Schlesinger et al., 1990).  
 
The MR is found on the surface of macrophages and it is implicated in the inhibition of 
fusion of phagosomes with lysosomes. When MR is blocked or absent, phagosome-lysosome 
fusion is enhanced, indicating that the entry via MR limits fusion of phagosomes with 
lysosomes (Kang et al., 2005). 
 
1.3.2 Cytokines involved in M. tb infection 
1.3.2.1 Common proinflammatory cytokines in regulation of M. tb 
 infection 
Interferon gamma (IFN-γ) is the chief cytokine in the activation of macrophages, with the 
aim to combat the infection (Reljic et al., 2010) by contributing to antibacterial activities 
induced by macrophages (Denis, 1991; Giacomini et al., 2011). IFN-γ plays a major role in 
controlling M. tb infection in host cells (Herbst et al., 2011; O’Leary et al., 2011; Rooyakkers 
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and Stokes, 2005). Administration of IFN-γ to TB patients was observed to improve the 
clearance of infection. In addition, mutation in the IFN-γ receptor and antibodies to IFN-γ 
lead to the spread of M. tb infection (Seneviratne et al., 2007); Dorman et al., 2004). In vitro, 
IFN-γ was observed to inhibit the growth and replication of the pathogen, whereas in vivo it 
was essential in the formation of granuloma and the containment of M. tb infection (Cooper 
et al., 1993; Flynn et al., 1993; Sechler et al., 1988) 
 
Interleukin 12 (IL-12) is involved in the generation of immune response against M. tb 
infection. It acts as an autocrine and paracrine to activate macrophages in order to induce 
antimicrobial response, including the production of IFN-γ (Giacomini et al., 2001; Robinson 
et al., 2010). Mice and humans deficient in IL-12 are highly susceptible to M. tb infection and 
are unable to control its growth, due to the absence of IFN-γ (Cooper et al., 1997; Jouanguy 
et al., 1999). Treatment with IL-12 is associated with the reduction of mycobacterial growth 
(Robinson and Nau, 2008). 
  
TNF-α is a potent proinflammatory cytokine which together with interferon-gamma (IFN-γ) 
plays an important role in activating antimicrobial activities in macrophages, including 
inhibition of mycobacterial growth (Giacomini et al., 2011; Sharma et al., 2004). TNF-α is 
essential in the control of TB in humans and it is involved in the formation of granulomas 
Infection of mice deficient in TNF-α with M. tb was reported to impair granulomas, leading 
to resuscitation of M. tb infection to TB disease (Bean et al., 1999; Silva Miranda et al., 
2012). Moreover, TNF-α is involved in induction of IFN-γ production, and apoptosis, during 
the early stages of M. tb infection (Beltan et al., 2000; Flynn et al., 1995; Giacomini et al., 
2001; Wu et al., 2012). 
 
1.3.2.2 Common immunosuppressive cytokines in regulation of M. tb 
infection 
IL-10 is a potent immune suppressant, therefore, its abundance is associated with decreased 
ability of the host to control M. tb infection (O’Leary et al., 2011; Oswald et al., 1992; 
Redpath et al., 2001). IL-10 is known for its role in inhibiting the functions of macrophages 
(Redford et al., 2011), such as the production of proinflammatory cytokines, thereby allowing 
growth of M. tb inside macrophages. IL-10 strongly suppresses IL-12 expression, resulting in 
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reduced production of IFN-γ and failure to eliminate M. tb infection (Cunha et al., 1992; 
Fiorentino et al., 1991; Giacomini et al., 2001; Gong et al., 1996). Furthermore, several 
studies have indicated that the absence of IL-10 during Mtb infection elicit phagosome 
maturation and bacterial clearance (Murray and Young, 1999; Via et al., 1998). 
 
TGF-β, like IL-10 decreases the activation of macrophages and the production of 
proinflammatory cytokines (Aung et al., 2000; Toossi and Ellner, 1998). The excessive 
production of TGF-β is coupled with the progression of M. tb infection to TB. TGF-β was 






















Figure 1.1 Different outcomes of M. tb infection and primary cytokines involved. A: High levels of proinflammatory
cytokines and fusion of phagosomes with lysosomes lead to M. tb elimination. A: 1- phagosome-lysosome fusion, 2-
enzymatic digestion and destruction of M. tb inside phagolysosome, 3- M. tb elimination. B: High levels of
immunosuppressive cytokines and inhibition of phagosome-lysosome fusion lead to active TB. C: During latent TB, IL-2 and
IL-8 are present in high levels and M. tb is dormant in the granuloma.
M. tb is active. It multiplies & 
progresses to TB disease
Active TB
B







M. tb is destroyed
Elimination of M. tb
Phagolysosome
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1.4 Selection rationale for the 12 genes studied 
1.4.1 Toll-like receptors (TLRs) 
TLR7 and TLR9 are members of the TLR family. They are endosomal PRRs found on cell 
surfaces (Avunje et al., 2011; Brown et al., 2011; Delgado et al., 2008). As PRRs, their 
primary role is to recognise invading pathogens and activate innate immunity in order to 
eliminate the invading pathogens (Crevel et al., 2002; De Meyer et al., 2012; Delgado et al., 
2008). TLR9 is nucleotide-sensing, it binds the pathogen’s DNA, leading to cell activation 
and proinflammatory cytokine secretion, via MyD88 (Chiang et al., 2012; Crevel et al., 
2002). TLR7 ligands such as imiquimod induce autophagy (De Meyer et al., 2012; Delgado 
et al., 2008), a defence mechanism of the innate immunity, aimed at eliminating intracellular 
pathogens through ingestion into autophagosomes for subsequent degradation by lysosomal 




IL-12 and IL-10 are classified as interleukins and are essential during M. tb infection (see 
sections 1.3.2.1 and 1.3.2.2). Cytokines are characterised as either proinflammatory or 
immunosuppressive. IL-12 is a proinflammatory cytokine and therefore plays a fundamental 
role in the immune response against invading pathogens, whereas, IL-10 is a potent 
immunosuppressive cytokine and functions to inhibit the immune response. IL-12 and IL-10 
have an antagonistic effect on one another. IL-10 inhibits the expression of IL-12, resulting in 
decreased IFN-ϒ synthesis and thereby failure to destroy M. tb. They are both reported to be 
among the most predominant cytokines in M. tb  infection (Giacomini et al., 2001). 
 
1.4.3 SNAREs 
Soluble N-ethylmaleimide-sensitive factor attachment protein receptors (SNAREs) are 
transmembrane protein molecules (Chen and Scheller, 2001). SNAREs were previously 
categorised as v-SNAREs and t-SNAREs based on their localisation on either vesicle 
membrane or target membrane, respectively. However, they have recently been classified as 
R-SNAREs (arginine-containing) or Q-SNAREs (glutamine-containing), based on their 
structural features (Fasshauer et al., 1998; Söllner et al., 1993). These proteins have been 
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implicated in the fusion events of all intracellular membranes, except for mitochondrial 
fusions (Chen and Scheller, 2001). VAMP7 is a v-SNARE or an R-SNARE and a primary 
inducer of late endosome-lysosome fusion (J Paul Luzio, 2009; Pryor and Luzio, 2009; 
Verderio et al., 2012). It is involved in heterotypic late endosome-lysosome fusion in alveolar 
macrophages (Advani et al., 1999; Pryor and Luzio, 2009; Ward et al., 2000). STX7 is a t-
SNARE or a Q-SNARE that is involved in late endosome-lysosome fusion, as well as 
homotypic lysosome fusion in vitro (Achuthan et al., 2008; Mashima et al., 2008; Ward et 
al., 2000). It was observed that the lack of transmembrane domain on STX7 and VAMP7 
blocks these fusions from occurring, suggesting that the transmembrane domains are essential 
in the induction of the endosome-lysosome fusion (Ward et al., 2000). Furthermore, the 
presence of an antibody against STX7 blocks lysosome fusion in vitro (Ward et al., 2000). 
STX4 is a t-SNARE induced by the activation of macrophages. It is involved in exocytic 
pathways and secretion of TNF-α, a proinflammatory cytokine (Pagan et al., 2003). The 
deletion of its transmembrane domain interferes with membrane trafficking and inhibits the 
production of TNF-α by macrophages, whereas its overexpression enhances the production of 
this cytokine (Pagan et al., 2003). Furthermore, STX4 has also been localised on the 
phagosomal membranes in macrophages (Hackam et al., 1996). 
 
1.4.4 Chemokines 
CCL1 is a chemokine that plays a role in the regulation of the immune system and 
inflammatory processes. It recruits monocytes to the site of infection, thereby resulting in the 
formation of granulomas. CCL1 is implicated in the regulation of genes involved in 
apoptosis, oxidative stress and chemotaxis in humans. In accordance with the latter, CCL1 
was identified to stimulate the expression of CCR8 (its receptor) and CCL2, a potent 
chemoattractant of macrophages involved in the invasion in many disease states. 
Furthermore, knockdown of CCR8 by siRNA was observed to inhibit the expression of CCL2 
(Tal et al., 2007). 
 
1.4.5 GANC 
GANC is a glycosyl hydrolase enzyme that plays a fundamental role in the metabolism of 
glycogen, a large alpha-glucan (α-glucan) molecule that serves as carbon/ energy storage in 
bacteria and enhances cell survival (Chandra et al., 2011). α-glucan is synthesised in the 
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GlgE pathway, which was recently discovered in mycobacteria (M. tb and M. smegmatis) and 
has been genetically validated as target for anti-TB drugs (Kalscheuer et al., 2010; Sambou et 
al., 2008). Furthermore, glycogen-like α-glucan molecule was identified in the mycobacterial 
capsule and has been implicated in immune evasion, rather than in energy storage (Gagliardi 
et al., 2007; Sambou et al., 2008). 
 
1.4.6 PKC-α 
PKC-α is a member of the protein kinase C (PKC) family, a family of serine- and threonine-
specific protein kinases. PKC-α is involved in signal transduction (Meisel et al., 2013; 
Teicher, 2006). It is implicated in phagocytosis of mycobacteria by macrophages and inhibits 
their subsequent intracellular survival (Chaurasiya and Srivastava, 2009, 2008). An infection 
of macrophages with M. tb or M. bovis BCG exhibited downregulation of PKC-α, whereas an 
infection with M. smegmatis leads to upregulation of this gene (Chaurasiya and Srivastava, 
2009, 2008). These observations concur with the report that M. tb and M. bovis BCG are less 
efficiently phagocytosed by macrophages, when compared to M. smegmatis. Moreover, 
PKnG, a protein involved in M. tb intracellular survival, was implicated in this 
downregulation of PKC-α, since it is found in both M. tb and M. bovis BCG, but not in M. 
smegmatis (Swartz et al., 1988). Furthermore, PKC-α plays a role in phagolysosome 
biogenesis (Chaurasiya and Srivastava, 2009). 
 
1.4.7 CLIC4 
CLIC4 is a protein involved in the channel of chloride (an electrolyte involved in pH balance) 
in the endoplasmic reticulum (ER), mitochondria and nucleus (Zhong et al., 2012). Although 
its role is still unclear, it is implicated in many biological processes such as signal 
transduction, cell differentiation and apoptosis (Shiio et al., 2006; Zhong et al., 2012). Zhong 
et al (2012) suggested CLIC4 as potentially indirectly involved in autophagy, based on the 
observations that, under imitated nutrient-free conditions autophagy was induced and CLIC4 
was upregulated. They further reported that autophagy was enhanced when CLIC4 was 
silenced via siRNA and apoptosis was triggered, under starvation conditions (Zhong et al., 
2012). Autophagy and apoptosis are the most common forms of programmed cell death 
induced under stressful conditions, and they are central to M. tb infection (Conradt, 2009; 
Elliott and Reiners, 2008). 




YWHAZ, also known as 14-3-3ζ is a binding protein that interacts with proteins involved in 
cell surface regulation, such as human vacuolar protein sorting 34 (hVps34) (Pozuelo-Rubio, 
2011). hVps34, the class III phosphatidylinositol-3-kinase, mediates processes involved in 
vesicle trafficking such as endocytosis and autophagy, and it is the key initiator of autophagy 
(Pozuelo-Rubio, 2012, 2011). The binding of 14-3-3 proteins to hVps34 implicates 14-3-3 
proteins in the regulation of autophagosome formation (Pozuelo-Rubio, 2012). Pozuelo-
Rubio (2012) reported the role of 14-3-3 proteins as negative regulators of autophagy, based 
on the observations that the forced expression of 14-3-3ζ decreased autophagy induced by 
C2-ceramide, whereas the reduction of 14-3-3ζ expression lead to increased autophagy. 
Further observations were that, the interaction of 14-3-3 proteins with hVps34 under 
physiological conditions inactivates hVps34, whereas under nutrient-free conditions 14-3-
3/hVps34 complex dissociates, leading to increased activation of hVps34 lipid kinase 
(Pozuelo-Rubio, 2012, 2011). Furthermore, 14-3-3 proteins are well-known inhibitors of 
apoptosis (Masters et al., 2002). 
 
1.5 Pathogenic versus non-pathogenic mycobacterial species 
The main difference between pathogenic and non-pathogenic mycobacteria is the ability of 
the pathogenic mycobacterial species to avoid or withstand the hostile, acidic macrophage 
environments, thereby allowing their intracellular survival and promoting their virulence 
(Anes et al., 2006; McDonough et al., 1993; Schlesinger, 1996; Simeone et al., 2012). The 
intracellular killing of non-pathogenic M. smegmatis and their inability to cause disease even 
in immuno-compromised individuals, may be linked to their attribute of strongly stimulating 
the innate immune response (Anes et al., 2006, Bohsali et al., 2010). Phagocytosis of 
microbes is normally followed by phagosomal trafficking to lysosomes for subsequent 
phagosome-lysosome fusion, an important mechanism used by macrophages to eliminate 
intracellular bacteria. However, pathogenic mycobacterial species such as M. tb can either 
prevent maturation, of phagosomes, thereby blocking their fusion with lysosomes (Clemens 
and Horwitz, 1995; Koul et al., 2004; Xu et al., 1994), or escape the phagolysosomes to 
multiply in non-fused phagosomes as well as in the cytoplasm (McDonough et al., 1993). In 
contrast, non-pathogenic mycobacterial species fail to block or escape phagosome-lysosome 
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fusion and therefore get digested by hydrolytic enzymes of lysosomes for subsequent 
degradation (Anes et al., 2006; McDonough et al., 1993). 
 
Infection of macrophages with pathogenic and non-pathogenic mycobacterial species induce 
different outcomes (McDonough et al., 1993; Simeone et al., 2012; Spira et al., 2003). Non-
pathogenic mycobacteria promote TNF-α-induced apoptosis, an immune response during 
which macrophages destroy the invading bacteria. The role of apoptosis in mycobacteria 
infection is still controversial as its outcome depends on the nature of the infecting stimulus 
(Divangahi et al., 2009; Keane et al., 2000; Lee et al., 2011, 2006; Spira et al., 2003)  
Pathogenic mycobacteria infecting macrophages can either induce apoptosis as a survival 
mechanism or evade apoptosis and induce necrosis, depending on the multiplicity of infection 
(MOI) and strain virulence (Keane et al., 2000; Spira et al., 2003). Infection with a high MOI 
and/ or a highly virulent strain results in necrosis, a process of cell death during which cell 
membrane lyses, allowing the pathogen to escape into the surrounding tissues and spread the 
infection. Necrosis is harmful to macrophages but beneficial to pathogens. Furthermore 
pathogenic mycobacteria induce lower production of cytokines in macrophages, as compared 
to non-pathogenic mycobacteria (Yadav et al., 2006). 
 
1.6 Selection rationale for the infection parameters 
The THP-1 cell line was chosen for its ability to resemble the morphology and mimic the 
response of human primary macrophages, when differentiated. Their homogenous genetic 
background minimizes the degree of variability in the cell phenotype and therefore produces 
reliable results. Since THP-1 cells are a human derived cell line, the results would be more 
relevant to compare to in vivo human infection (Qin, 2012). 
 
M. tb is a pathogen that exhibits similar attributes to M. bovis BCG in that they both have a 
slow growth rate (24 h doubling time) (Bettencourt et al., 2010) and are able to survive inside 
macrophages (McGarvey et al., 2004; Walburger et al., 2004). However, M. bovis BCG is 
regarded as non-pathogenic due to the absence of the RD1 region that was found to be 
conserved in all pathogenic mycobacteria (Lewis et al., 2003; Majlessi et al., 2005). 
However, if the infected individual is immunocompromised, M. bovis BCG can cause disease 
(Hesseling et al., 2003; Zhou et al., 1999). M. smegmatis is a non-pathogenic mycobacterial 
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species with a rapid growth rate (3 h doubling time) (Bettencourt et al., 2010) and is killed by 
macrophages (Anes et al., 2006). Therefore, the rationale for selection of these 3 species was 
based on their killing or survival inside macrophages and they were considered suitable to 
distinguish if the transcriptional response is specific to macrophages. 
 
An MOI of 1 was considered more feasible for this study since it is one of the commonly 
used MOIs in literature, due to its ability to stimulate gene expression without causing 
damage or cell death to the macrophages. Moreover, this MOI was more suited for this study, 
since about 90% of mycobacteria cultured without Tween 80 (to an OD600 of 0.3) were 
present in clumps, which were subsequently removed by filtration in processing for infection, 
resulting in low CFU counts (see Figures 3.1-3.3). 
  
1.7 The effect of Tween 80 in mycobacterial cell wall  
Mycobacteria are known for their unique cell wall, which resembles that of Gram positive 
bacteria due to the lack of an outer membrane, yet consist of a lipid bilayer as observed in 
Gram negative bacteria (Etienne et al., 2002; Masaki et al., 1991; Sani et al., 2010). The 
complexity of the extracellular capsule of the mycobacterial cell wall is associated with its 
low permeability to many toxic compounds such as antibiotics, which therefore contributes to 
the virulence of mycobacteria (Ehrt and Schnappinger, 2009; Hoffmann et al., 2008; Nguyen 
and Pieters, 2009; Sani et al., 2010). Mycolic acids are the major lipids present in 
mycobacterial cell wall and they are implicated in pathogenesis of mycobacteria and evasion 
of immune response by mycobacteria (Takayama et al., 2005). Moreover, the lipid 
constituents of the mycobacterial cell wall are responsible for the excessive clumping of the 
mycobacterial cells in liquid culture. The absence of clumps is important for macrophage 
infections, since these are rapidly trafficked to phago-lysosomes in macrophages, in contrast 
to phagosomes containing single mycobacteria (Figure 1.2) (Bettencourt et al., 2010). 
Furthermore, the host macrophage response to mycobacterial infection depends on the 
bacterial load (MOI) and the percentage of infected macrophages. Infection with clumped 
mycobacteria result in a relatively higher variability in the number of mycobacteria present in 
each macrophage: some macrophages may contain excessive mycobacterial load, whereas 
others may not contain any bacilli (Bettencourt et al., 2010). In order to minimize excessive 
clumping, the growth medium for mycobacterial cultures is normally supplemented with 
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Although Tween 80 aids in reducing clumping in mycobacterial cultures, it has been 
observed to solubilise the mycobacterial extracellular capsule (see examples in Figures 1.3 
and 1.4), resulting in the loss of the cell wall lipids that are implicated in mycobaterial 
virulence (Józefowski et al., 2008; Sani et al., 2010). To support this, a study by Van Boxtel 
et al (1990) reported that the Myobacterium paratuberculosis (M. paratuberculosis) strain 
was able to grow optimally in a drug-containing medium without Tween 80, but was unable 
to grow in the presence of Tween 80.  The authors speculated that Tween 80 compromises 
the resistance of the M. paratuberculosis strain to antimicrobial agents (Van Boxtel et al., 
1990). A similar observation was shared by other antimicrobial susceptibility studies with M. 
avium and M. intracellulare, wherein it was suggested that the increased permeability of 
drugs into the mycobacteria was due to the perturbed mycobacterial cell wall by Tween 80 
(Naik et al., 1988). 
 
Furthermore, it was revealed that Tween 80 supplemented in liquid culture medium was 
responsible for the structural changes observed in Mycobacterium avium complex (MAC). It 
was observed that in the presence of Tween 80 the cells of the S-139 M. avium strain were 
Figure 1.2: Confocal microscopy image of J774 macrophages infected with M. smegmatis–GFP after 1h uptake.
Red: actin labeled using Rhodamine-Phalloidine staining; Green – Green Fluorescent Protein expressing
bacteria. A: round-shaped macrophages containing unicellular M. smegmatis B: irregular-shaped macrophages
containing clumps of M. smegmatis. Clumped bacteria triggered recruitment of F-actin and Hck at the phagosomes,
events associated with lysosome fusion. Adapted from Bettencourt et al., 2010.
A B
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elongated and the fibrillar material present in the L1 layer, a sheath that is thought to protect 
M. avium inside macrophages, disappeared. However, when the same cells were re-cultured 
without Tween 80, their size returned to normal and the fibrillar material was present in the 
L1 layer (Masaki et al., 1991). 
 
Consequently, the inclusion of Tween 80 in mycobacterial cultures remains dubious 
regarding whether the ex vivo interaction between macrophages and mycobacteria mimics the 
in vivo infection state. Based on the known damaging effect of Tween 80 on the 
mycobacterial cell wall, all the strains were cultured without Tween 80 to ensure that the cell 
wall remains intact (Masaki et al., 1991; Sani et al., 2010; Van Boxtel et al., 1990). Despite 
this, most studies still make use of Tween 80 for culturing mycobacteria, therefore the strains 
were also cultured with Tween 80 to serve as reference and for comparison purposes to 
determine if Tween 80 perturbations on the  mycobacterial cell wall affect  the gene 
expression profile of macrophages. With the above said, the current study intended to 
investigate gene expression in differentiated THP-1 cells in response to mycobacterial species 
cultured in the presence or absence of Tween 80. 
 
 
Figure 1.3 Visualization of the capsule in its native state. Cryo electron micrographs of intact Gram- negative
bacterium S. flexneri cultured without Tween 80 and plunge frozen (A) depicts the typical cell envelope profile
using this method of sample preparation. S flexneri is used as a control to illustrate the absence of the capsule
that is of mycobacterial origin. (B) M. smegmatis cells cultured with both Tween 80 and agitation show a cell
envelope with morphology similar to S. flexneri. (C) M. smegmatis, (D) M. tb, (E) M. marinum and (F) M. bovis
BCG cells cultured without Tween 80 (before freezing) show the presence of an extra layer (bracket)
surrounding the mycomembrane. Adapted from Sani et al., 2010.





1.8 Problem Statement and Motivation 
The TB epidemic remains a global burden and this is partly fuelled by the current anti-TB 
treatment that is failing due to the emergence of drug resistant strains (Fakruddin, 2013; 
WHO, 2010; Yokobori et al., 2013). The existing anti-TB drugs target mycobacterial 
enzymes and pathways (De La Iglesia and Morbidoni, 2006; Mdluli and Ma, 2007; Timmins 
and Deretic, 2006; Walsh, 2000) and in response, the mycobacteria have developed resistance 
against the drugs (WHO, 2010). A novel approach is therefore required to develop drugs that 
will have an indirect bactericidal effect thereby limiting the possibility of the development of 
drug resistance. Host directed anti-tubercular therapy might be a solution, as no drug 
resistance is likely to develop when the drugs are directed to host factors. In order to apply 
this approach, knowledge of the host factors that are involved in the intracellular survival of 
M. tb is necessary (Jayaswal et al., 2010; Li et al., 2006). 
 
Figure 1.4 Effect of detergent on the localization of capsular components and the detection of ESX-1 proteins.
M. smegmatis (A and B) and M. tuberculosis (D and E) were cultured with (A, D) and without (B, E) Tween 80,
fixed and probed with anti-a-glucan (A–B) and anti PIM/capLAM (D–E) to demonstrate that this extra layer was of
capsular origin. They used antibodies that recognize α-glucan and PIMs, components associated with the capsule.
Surface of mycobacteria cultured without Tween 80 (B, E) were distinctly labelled with these antibodies and surface
of mycobacteria cultured with Tween 80 (A, D) showed weak or no labelling. Adapted from Sani et al., 2010.
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1.9 Hypothesis  
Host macrophage genes that are differentially expressed by pathogenic and non-pathogenic 
mycobacteria potentially affect the survival of M. tb inside macrophages. Furthermore, 
mycobacteria cultured in the presence of Tween 80 induce different transcriptional 
macrophage responses from mycobacteria cultured without Tween 80. 
 
1.10 Aim 
To generate single cells from mycobacteria cultured without Tween 80 and determine if 
perturbations in mycobacterial cell wall caused by Tween 80 will affect transcriptional 
macrophage response. Furthermore, to determine the differential expression of a subset of 
macrophage genes and identify the ones that potentially affect M. tb survival in macrophages. 
 
1.11 Objectives 
1. Culture mycobacteria in liquid medium with and without Tween 80 
Mycobacteria tend to form clumps when grown in liquid culture due to its high lipid 
constituents in the cell wall (Bettencourt et al., 2010). Therefore, detergent such as Tween 80 
is used to minimize the formation of major clumps. However, there is considerable literature 
showing that Tween 80 has an adverse effect on mycobacterial cell wall integrity, thereby 
compromising its virulence (Sani et al., 2010; Van Boxtel et al., 1990). Thus, mycobacterial 
strains will be cultured in the presence or absence of Tween 80. 
 
2. Infect differentiated THP-1 cells with M. tb, M. bovis BCG and M. smegmatis 
M. tb and M. bovis BCG have the ability to survive inside macrophages, whereas M. 
smegmatis lacks this ability and is killed. In addition, M. tb is a pathogenic mycobacterial 
species, whereas M. bovis BCG and M. smegmatis are non-pathogenic (Anes et al., 2006; 
McGarvey et al., 2004; Walburger et al., 2004; McDonough et al., 1993). Therefore, 
infecting differentiated THP-1 cells with these 3 strains will enable us to determine the 
macrophage responses that potentially affect the intracellular survival of M. tb. 
 
Stellenbosch University  http://scholar.sun.ac.za
18 
 
3. Identify genes that are differentially expressed by M. tb, M. smegmatis and  
M. bovis BCG. 
M. tb is an intracellular mycobacterial parasite that depends on host factors for survival inside 
macrophages. Knowledge of the host macrophage genes that are upregulated or 
downregulated by M. tb but not by M. smegmatis and to a lesser degree by M. bovis BCG is 
necessary for identifying the host factors that potentially affect M. tb survival inside 
macrophages. Furthermore, this knowledge will contribute to the development of host 






















Materials and Methods 
 
2.1 Culturing of Mycobacteria 
 2.1.1 Culturing of M. tb and M. bovis BCG in Tween 80-enriched medium 
M. tb Beijing R179 (drug resistant clinical strain) and M. bovis BCG Pasteur were obtained 
from our departmental strain bank. The mycobacteria were cultured in T25 flasks (NUNC, 
Germany) by inoculating a 1 ml frozen stock in 9ml of Middlebrook 7H9 (BD, France) 
medium enriched with oleic acid, albumin, dextrose and catalase (OADC; BD, France) 
(Growth medium),  supplemented with 0.05% Tween 80 (Sigma Aldrich, UK) and incubated 
at 37°C and 5% CO2. When the cultures reached an Optical Density (OD600) of 0.8, a 1 ml 
was inoculated in T75 flask (NUNC, Germany) containing 49 ml growth medium 
supplemented with 0.05% Tween (which will henceforth be referred to as growth medium
T
) 
and incubated at 37°C until an OD600 ≈ 0.8. One ml aliquots containing 15% glycerol were 
stored at - 80°C until use. The culturing of M. bovis BCG and M. smegmatis was conducted 
inside the Biohazard class II hood; whereas M. tb was cultured under Biosafety level 3 
conditions, due to its high level of pathogenicity. Culturing method adapted from (Sani et al., 
2010). 
 
  2.1.2 Culturing of M. tb and M. bovis BCG in growth medium without Tween 80 
This methodology was developed in order to culture mycobacteria without compromising the 
integrity of their cell wall, as a result of the presence of detergents such as Tween 80 in the 
culture medium. A 1 ml frozen stock of M. bovis BCG or M. tb was split equally and 
inoculated into two T25 flasks containing 9 ml of growth medium without Tween 80 
(henceforth, will be referred to as  growth medium
NT
) and grown to an OD600 ≈ 0.3 at 37°C.  
Subcultures were prepared by splitting each T25 flask into 5 flasks containing 8 ml growth 
medium
NT
. At OD600 ≈ 0.3 each flask was split into 2 flasks, such that each contained 5 ml 
bacterial culture and 5 ml growth medium
NT
, where after they were subsequently re-
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incubated at 37°C until OD600 ≈ 0.3. The flasks were then combined in 4 separate 50 ml tubes 
and left to stand for 30min at room temperature in order to sediment the major mycobacterial 
clumps. The top 45 ml of each tube was transferred to a new 50 ml tube, centrifuged at 450 
xg for 5 min and each pellet was resuspended in 5 ml growth medium
NT
. The bacterial 
suspensions were combined, mixed and left to stand for another 15 min, at room temperature. 
The top 17 ml was transferred to a new 50 ml tube and 1 ml aliquots containing 15% glycerol 
were stored at -80°C until use.  
 





 155 was kindly donated by a colleague (Sao Emani et al., 2013). The 
frozen stock of M. smegmatis was inoculated in a 100 ml Erlenmeyer flask containing 10 ml 
growth medium
T
, to starting OD600 of 0.0025. The culture was covered with foil and 
incubated at 37 °C with shaking (200 rpm). At OD600 ≈ 0.8, the culture was inoculated in a 
500 ml Erlenmeyer flask containing 50 ml growth medium
T 
to starting OD600 of 0.0025, 
incubated at 37 °C until it reached an OD600 ≈ 0.8. 1 ml aliquots containing 15% glycerol 
were stored at -80 °C until use. 
 
 2.1.4 Culturing of M. smegmatis in growth medium
NT
 
M. smegmatis was cultured in growth medium
NT
 in a similar fashion as in growth medium
T 
(section 2.1.3). However, the starting culture and the subculture were grown to an OD600 of 
0.3, due to excessive clumping observed beyond this OD600. 
 
Please note: henceforth, all mycobacteria cultured with Tween 80 will be annotated with (
T
) 
and the ones cultured without Tween 80 will be annotated with (
NT
). When referring to 




2.1.5 Contamination assessment of mycobacteria
T/NT
 
Blood agar plating and Ziehl-Neelsen (ZN) staining were performed on mycobacterial 
cultures as well as on stocks to assess the presence/ absence of contamination. ZN stains were 
also used to examine the morphology and the level of clumpiness of the mycobacterial cells. 
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  2.1.5.1 ZN staining 
The ZN staining was performed according to the standard protocol (Bishop and Neumann, 
1970). An aliquot (50 µl) of mycobacterial culture was smeared and fixed on a glass slide by 
heating at 80°C for 2 hours or overnight. Formalin (10%)  (BD, France) was used as a 
fixative for M. tb cultures in order to ensure proper fixation. Mycobacteria were stained with 
carbol fuchsin (BD, France), heated until steam appeared and allowed to stand for 5 min 
before rinsing with water. The bacteria were decolourised with acid-alcohol, left to stand for 
2 min and then rinsed with water. Methylene blue (BD, France) was then added and left to 
stand for 2 min to counterstain. Next, the slide was air-dried and examined microscopically 
under oil immersion (100X magnification). The staining method was performed according to 
(Bishop and Neumann, 1970). 
 
  2.1.5.2 Blood Agar plates 
An aliquot (40 µl) of M. bovis BCG and M. tb cultures were plated on blood agar (BD, 
France) and incubated at 37°C for 48 hours, in order to assess the sterility of the cultured 
mycobacteria. In addition, 7H9 (BD, France) medium was plated on the same plates to serve 
as a control, thereby confirming the sterility of the plates. M. tb and M. bovis BCG do not 
grow on blood agar within 48 hours. Therefore, any growth observed within 48 hours is 
considered as contamination. In contrast, M. smegmatis has a rapid growth rate and was 
therefore not examined with this method. 
 
2.1.6 Determining the mycobacterial
T 
titre 
For determination of colony forming units (CFUs) in mycobacteria
T
, three frozen stock vials 
of each of the mycobacterial strains (M. tb, M. bovis BCG and M. smegmatis) were thawed 
and passed 15X through a 25G needle connected to a 1 ml syringe as means of breaking up 




) were prepared with growth medium
T
 for each of the 




 dilutions were cultured on Middlebrook 
7H11 (BD, France) agar plates, followed by incubation at 37°C until colonies were visible. 
CFUs were calculated using the 10
-5 
dilution plates, on which between 30 and 300 colonies 
were observed. 
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 2.1.7 Determining the mycobacterial
NT 
titre 
For determination of CFUs in mycobacteria
NT
, three frozen stock vials of each of the 
mycobacterial strains were thawed, syringed 15X with a 25G needle and left to stand for 30 
min to allow the major clumps to sediment. The top 750 µl of each stock vial was diluted to 5 
ml with mycobacterial growth medium, mixed with a pipette and subsequently filtered 









 dilutions were 
plated out on Middlebrook 7H11 agar plates and incubated at 37°C until colonies were 
observed. The 10
-3
 dilution plates were used to calculate the CFUs, since they showed colony 
counts between 30 and 300.  
 
2.2 Tissue culture 
 2.2.1 Growth of THP-1 cells 
A frozen stock vial of THP-1 cells (ATCC 88081201) was thawed, washed with 20 ml RPMI 
1640 (Sigma Aldrich, USA) to remove Dimethyl Sulfoxide (DMSO) and subsequently 
cultured in complete medium (RPMI 1640 enriched with 10% Heat-inactivated Fetal calf 
serum (FCS; Biochrome, Germany) supplemented with 100 U/ml Penicillin and 100 µg/ml 
Streptomycin (Pen-Strep) (Sigma Aldrich, USA), to limit bacterial contamination. The cells 




 day and the 
cells were passaged or split when a confluence of 70-80% was reached. Medium change and 
passaging or splitting of the cells was established by centrifugation followed by re-suspension 
in complete medium supplemented with Pen-Strep. The culturing method was performed 
according to (Park et al., 2007) with some modifications. 
 
 2.2.2 Cell counting using haemocytometer  
To prepare for counting, the THP-1 cell culture was transferred to a 50 ml tube and 
centrifuged at 240 xg for 3 min. After the supernatant was discarded, the pellet was 
resuspended in 10 ml mycobacterial growth medium. Twenty five microlitres of the cell 
suspension was mixed with 75μl of Trypan blue (Thermo Scientific, USA) (1:4 dilution) in a 
1.5 ml tube and 20 μl of the mixture was transferred to a haemocytometer (Marienfield, 
Germany) for counting. The cells were visualised and counted under an inverted light 
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microscope (Nikon). The number of live cells (shiny) was counted against the number of 
dead cells (blue) to determine cell viability. 
 





 split, cells were resuspended in complete medium, seeded at 3X10
6
 
cells per well in 6-well plates (Nunc, Germany) and differentiated into macrophage-like cells 
with  Phorbol 12-Myristate 13-Acetate (PMA; Sigma Aldrich, USA) at a final concentration 
of 100 nM. After 48 hours at 37°C under 5% CO2, the cells were washed with warm RPMI 
1640 and reincubated for another 24 hours in complete medium supplemented with PMA at 
final concentration of 100 nM, to ensure complete differentiation. Henceforth, PMA-
differentiated THP-1 cells will be referred to as dTHP-1 cells. The differentiation method was 
performed according to (Park et al., 2007) with some modifications. 
 
2.3 Infection of dTHP-1 cells with mycobacteria
T/NT
 
 2.3.1 Processing of mycobacteria
T
 for infection 
A frozen stock vial of mycobacteria
T
 was thawed in a 37°C water bath and subsequently 
passed 15X through a 25G needle connected to a 1 ml syringe in order to disrupt the clumps 
(our standard laboratory procedure). The required amount of mycobacteria (based on the 
Multiplicity of Infection (MOI) and number of cells to be infected) was transferred to a new 
1.5 ml tube and centrifuged at 14 000 x g for 5 min, in order to remove the Tween 80 the 
mycobacteria was cultured in. The pellet was resuspended in 1 ml growth medium and passed 
10X through a 25G needle connected to a 1 ml syringe and diluted in growth medium to the 
required volume  which was then passed through a 5 µm pore sized filter (Sartorius, 
Germany); according to Sani et al., (2010), with modifications, to remove any remaining 
clumps. 
 
 2.3.2 Processing of mycobacteria
NT
 for infection 
Frozen stocks of mycobacteria
NT
 were prepared for infection in the same fashion as 
mycobacteria
T
 (see section 2.3.1). However after syringing 10X, the pellet resuspension was 
diluted to 5 ml with complete medium to prevent filter blockage due to clumps. The required 
amount of the diluted bacterial suspension was topped up with complete medium to the final 
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volume required for infection. 
 
 2.3.3 Infection procedure 
The dTHP-1 cells were infected with pathogenic and non-pathogenic mycobacteria
T/NT 
(cultured with or without Tween 80) at an MOI of 1 (1 bacillus per dTHP-1 cell). The cells 
were allowed to phagocytose the bacilli for 3 h after which they were washed 4X with ice-
cold Phosphate Buffer Saline (PBS; Sigma Aldrich, USA) to remove extracellular 
mycobacteria, and re-incubated at 37°C under 5% CO2 for further time points (8 h, 24 h and 
48 h). The experiment was conducted in biological duplicates and technical duplicates. 
 
2.4 RNA extraction 
RNA was extracted at 3hr, 8hr, 24hr and 48hr time points from the biological duplicates and 
technical duplicates of dTHP-1 cells infected with the pathogenic and non-pathogenic 
mycobacterial strains cultured with and without Tween 80, as well as from the uninfected 
cells which served as the control, using the RNeasy Plus Mini Kit  (Qiagen, Germany) 
according to the manufacturer’s instructions. Briefly, the cell culture medium was completely 
aspirated from the cells and the cells were washed 3X with ice-cold PBS in order to 
completely remove any traces of the medium.  Cells were lysed by the addition of RLT buffer 
containing 10 µl/ml β-mercaptoethanol (Sigma Aldrich, USA) and homogenised by 
transferring the lysate to QIAshredder spin columns which were vortexed and centrifuged for 
2 min at maximum speed in a microcentrifuge. The lysate was transferred to the genomic 
DNA (gDNA) Eliminator spin columns, vortexed and centrifuged for 1 min at 8 000 xg, to 
remove gDNA. 350 µl of 70% ethanol was added to the flow through, mixed and transferred 
to RNeasy spin columns and centrifuged for 30s at 6 000 xg to precipitate RNA onto the spin 
column membrane. The flow through was discarded and the RNA bound to the membrane of 
the RNeasy spin column was washed with RW1 buffer and twice with RPE buffer to remove 
the contaminants. The RNeasy spin columns were placed in new 2 ml collection tubes and 
centrifuged for 1 min at maximum speed in order to remove the residual buffer. The RNeasy 
spin columns were placed in new 1.5 ml tubes and the total RNA was eluted by the addition 
of 30 µl RNase-free water directly to the spin column membrane and centrifuged for 1 min at 
8 000 xg. This step was repeated with the same eluate. The RNA was stored at - 80°C.  
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2.5 RNA quality control  
2.5.1 Assessment of gDNA contamination   
Polymerase chain reaction (PCR) (Table 2.2) using the HotStart polymerase (Qiagen, 
Germany) was performed on the RNA samples and the reaction products were 
electrophoresed on a 1% agarose gel for 1 h at 100 volts. Given the fact that PCR amplifies 
DNA only, the extracted RNA was used as the template for the PCR amplification in order to 
verify the absence of gDNA traces. The positive and negative controls were included for 
verification of positive amplification and purity of the PCR reagents, respectively. ACTB 
primer set (Table 2.1) was used for PCR amplification. The gel was visualised under UV 
light. Since PCR amplifies DNA only, any bands observed on the lanes of the negative 
control and RNA samples are considered as gDNA contamination or primer dimers (which 
are visible after Gel electrophoresis of the PCR product, about 30-50 bp or smear which has a 
distinguishable intensity from the  band of the target sequence).  
 
2.5.2 Assessment of RNA integrity  
The Agilent 2100 Bioanalyzer (version 2.6) (Agilent Technologies, USA) is an automated gel 
electrophoresis system that calculates the integrity of RNA to provide a quantitative measure 
of the RNA quality. Good quality (intact) RNA is indicated by the 28S/18S ratio of 2, 28S 
bands with double intensity and size compared to the 18S bands, absence of heavy smearing 
around the bands, height of the 28S peaks that is double that of the 18S, sharp peaks and 
RNA integrity number (RIN) that is between 8 and 10. RIN calculates a numerical value from 
1 to 10 with a score of 1 indicating the most degraded RNA and 10 indicating the most intact 
RNA (Nolan et al., 2006) 
 
2.6 cDNA synthesis 
For all the samples 1 µg of RNA was converted to cDNA using the QuantiTect Reverse 
Transcription kit (Qiagen, Germany). 2 µl gDNA ‘Wipeout Buffer’ and water were added to 
each RNA sample to make up a total volume of 14 µl and then incubated at 42°C for 2 min in 
order to eliminate gDNA contamination in the RNA samples. To convert RNA to cDNA, 6 µl 
of the master mix (1 µl RT enzyme, 4 µl RT buffer and 1 µl Primer mix) was added to make 
up 20 µl reactions, which were incubated at 42°C for 20 min and at 95°C for another 3 min. 
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The cDNA samples were stored at -20°C until use.  
 
2.7 Quantitative Real Time-PCR  
The Quantitative Real Time-PCR (qRT-PCR) (Table 2.3) was performed using the 
LightCycler® 480 Faststart SYBR Green 1 Master kit (Roche, Germany). The efficiencies of 





) from the cocktail of all the cDNA samples and 10 µl reactions 
containing 7 µl H2O, 1 µl primer set, 1 µl SYBR Green mix and 1 µl cDNA template, were 
prepared. Primer efficiency testing was performed to ensure that the primer sets will work 
optimally as well as  to determine what concentration of cDNA was required to use in the 
experiment to identify  the changes in gene expression. Subsequent to primer efficiency 
verification, the expressions of the 12 target genes and 3 reference genes (Table 2.1) were 
analysed. The LC480 results were analysed further using the REST programme, in which the 
expression of each of the 12 target genes was normalised relative to the expression of the 
reference gene (ACTB, was used for normalisation of RNA levels because it had the most 
consistent expression across different samples), according to the 
  
(       )
         (              )
(    )
      (              )  formula, whereby the infected dTHP-1 cells (sample) are 
compared to the uninfected dTHP-1 cells (control). REST is a statistical programme in which 
a p-value ≤ 0.05 is considered as significant. The statistical test behind REST programme is 
a Randomised Pair Wise test, where two groups (control versus sample) are compared (Pfaffl 



















Table 2.1 List of validated QuantiTect primer sets (forward and reverse primers; Qiagen, 
Germany). Bioinformatically validated for use in SYBR Green-based qRT-PCR on any cycler. Primer 









Gene  QT number Amplicon size 
Syntaxin-7 (STX7) 
QT00091917 146 bp 
Toll-like receptor 9 (TLR9) QT00015183 77 bp 
Glucosidase, alpha; neutral C (GANC) 
QT01001105 105 bp 
Interleukin-10 (IL-10) 
QT00041685 113 bp 
Syntaxin 4 (STX4) 
QT00014679 126 bp 
Toll-like receptor 7 (TLR7) QT00030030 79 bp 
Chemokine ligand 1(CCL1) 
QT00203154 174 bp 
Vesicle-associated  membrane protein 7 (VAMP7) 
QT00006664 101 bp 
Chloride intracellular channel 4 (CLIC4) 
QT00058170 97 bp 
Protein kinase C, alpha  (PRKCA) QT00095746 97 bp 
Tyrosine-3-monooxygenase/tryptophan(YWHAZ) 
QT00087962 147 bp 
Interleukin-12 beta (IL-12β) 











Beta actin (ACTB) QT00095431 146 bp 
Beta-2- Microglobulin (B2M) QT00088935 98 bp 
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) QT00079247 122 bp 
Table 2.2 PCR parameters 
Reaction Temperature (°C) Time Cycle no. 
Enzyme (Taq) activation 95 15 min 1 
Template denaturation 94 30s 40 
Annealing of primers 60 30s 
Extension 72 1 min 
Proof reading 72 10 min 1 
Hold 4 ∞  

































Table 2.3 qRT-PCR parameters 
Reaction Temperature (°C) Time Cycle no. 
Enzyme (Taq)  activation 95 15 min 1 
PCR: 
Template denaturation 












Cooling 4 10s 1 
Table 2.4 Primer efficiencies 
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Table 2.5 ACTB consistent expression across uninfected and M. tb infected 
samples. This table is a representative example of ACTB expression values for M. 
























11.38 11.98 11.5 11.98 11.98 11.5 
11.39 11.92 11.14 11.93 11.92 11.28 
11.35 11.98 11.52 11.92 11.98 11.52 
11.58 11.82 11.13 11.82 11.82 11.27 
11.62 11.93 11.52 11.98 11.93 11.52 















12.54 11.56 12.68 11.49 11.26 11.56 
11.47 11.53 13.55 11.28 11.22 12.36 
12.21 11.54 12.71 11.23 11.28 11.57 
11.47 12.38 13.58 11.22 11.39 12.38 
12.24 12.4 12.72 11.41 11.41 11.54 





















Results and Discussion 
 
3.1 Results 
In the present study a total of 12 genes (Table 2.1) of the dTHP-1 cells were investigated for 
differential expression in response to infection with M. tb (3h, 24h and 48h), M. bovis BCG 
(3h, 24h and 48h) and M. smegmatis (3h and 8h), cultured with and without Tween 80, using 
the LightCycler
®
 480 (LC480) version 1 (Roche, Germany). (see Table 2.3 for PCR 
conditions). The results were analysed further on the REST programme to determine 
differential gene expression. 
 
ZN staining was conducted to assess possible contamination as well as the uniformity of 
mycobacteria cultured with or without Tween 80. The acid-fast bacteria (AFB) retained the 
pink colour of carbol fuschin and appear as pink-bright red rods on a blue background (due to 
counterstaining with methylene blue), whereas non-AFB are destained and pick up the blue 
colour of the methylene blue (Figures 3.1 and 3.3). M. smegmatis was observed to have an 
exception of staining both pink and blue (Figure 3.2). It was speculated that this may be 
because M. smegmatis is less acid-fast. However, no supporting studies could be found in the 
literature. To rule out contamination, the morphology (shape and size) of the cells was closely 
assessed and it was observed to be the same for both the pink and the blue rods, indicating 
that it is the same species (M. smegmatis). This verification was supported by the Southern 
blot results obtained in a previous study, in which the right size of an expected band was 
observed (Sao Emani et al., 2013). 
 
3.1.1 Evaluation of ZN slides to determine uniformity of mycobacteria 
 The mycobacterial cultures formed tighter clumps in growth medium
NT
, but loose and 
smaller clumps in growth medium
T
 (Figures 3.1-3.3). 
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Figure 3.1 ZN slides of the processing of M. tb for infection of dTHP-1 cells
under oil immersion (100X objective X 10X ocular magnification). a-d: M. tbT
and e-h: M. tbNT a & e: raw, b & f: syringed 15X, c & g: centrifuged and syringed
10X (following the 15X syringing), d & h: Diluted 5X and then filtered through a 5
µm pore filter. The arrows depict single mycobacterial cells. The blue background
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Figure 3.2 ZN slides of the preparation of M. smegmatis for infection of THP-1
macrophage-like cells under oil immersion (100X objective X 10X ocular
magnification). a-d: M. smegmatisT and e-h: M. smegmatisNT a & e: raw, b & f:
syringed 15X, c & g: centrifuged and syringed 10X (following the 15X), d & h:
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Figure 3.3 ZN slides of the preparation of M. bovis BCG for infection of
THP-1 macrophage-like cells under oil immersion (100X objective X 10X
ocular magnification). a-d: M. bovis BCGT and e-h: M. bovis BCGNT a & e:
raw, b & f: syringed 15X, c & g: centrifuged and syringed 10X (following the
15X), d & h: Diluted 5X and then filtered through a 5 µm pore filter. The arrows
depict single mycobacterial cells.
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In order to obtain a single cell (clump-free) mycobacterial suspension in preparation for the 
infection of dTHP-1 cells, a mycobacterial frozen stock was syringed twice (15X and then 
10X subsequent to centrifugation) with a 1 ml 25G needle in order to break up the clumps. 
Following syringing, the required volume of mycobacteria was mixed with RPMI 1640 plus 
10% FCS and the suspension was passed through a 5 µm pore filter to eliminate the 
remaining clumps and allow single mycobacterial cells to pass through. The filtration process 
was performed for both mycobacteria cultured with and without Tween 80 to ensure a clump-
free mycobacterial suspension. Even though the mycobacteria
T
 had relatively minor clumps 
and more single cells, the filtration step was performed to ensure uniformity between the 
treatment protocols for mycobacteria cultured with and without Tween 80.  
 
The ZN slides (Figures 3.1-3.3) confirmed that the mycobacteria
T
 have relatively more single 
cells and minor clumps (Figures 3.1-3.3: a). Although minor clumps were formed despite the 
presence of Tween 80 in the culture medium, the clumped cells separated as mycobacteria 
were syringed 15X (Figures 3.1-3.3 b). Following centrifugation and 10X syringing, the 
clumps disappeared almost completely and the number of single cells increased (Figures 3.1-
3.3: c), confirming the effectiveness of Tween 80 in reducing the formation of mycobacterial 
clumps. A clump-free mycobacterial suspension was obtained through filtration with a 5 µm 
pore filter (Figures 3.1-3.3: d).  
 
Approximately 90% of the mycobacteria cultured without Tween 80 were present in clumps 
(Figures 3.1-3.3: e). Although the clumps were in the majority, there were some 
mycobacteria that were in single form. Subsequent to syringing twice, i.e 15X (Figures 3.1-
3.3 f) and then 10X, following centrifugation (Figures 3.1-3.3 g), excessive major clumps 
remained. This observation suggests that mycobacteria form tighter clumps when cultured in 
liquid medium without Tween 80. Hence, it was necessary to filter the mycobacterial 
suspension in order to get rid of the clumps. Following filtration, all the major clumps were 
removed and only mycobacteria in single form and small clumps (containing 2 to 3 bacteria) 
were remained (Figures 3.1-3.3 h). 
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3.1.2 Quality and quantity assessment of total RNA 
RNA was extracted from the biological and technical duplicates of infected and uninfected 
macrophage-like cells, at 3 h, 24 h and 48 h time points for M. tb and M. bovis BCG 
infections and 3 h and 8 h for M. smegmatis infections. The quality and quantity of total RNA 
was assessed using the Bioanalyzer and Gel electrophoresis of PCR products. The extracted 
total RNA was intact and free of gDNA contamination and other impurities.  
 
 


















1     2       3       4       5       6      7       8       9    10     11    12     13       14     15 16
Figure 3.4 Gel Electrophoresis of the PCR products. Lane 1: Marker (GeneRulerTM
100bp DNA ladder plus), Lane 2-14: RNA samples, Lane 15: negative control (template
= water) and Lane 16: positive control (template = DNA). Lanes 2-7 consist of M. tb
experiment: 2&3 are controls, 4&5 are samples infected with M. tb NT and 6& 7 are
samples infected with M. tbT. Lanes 8-13 consist of M. smegmatis experiment: 8& 9 are
controls, 10& 11 are samples infected with M. smegmatisNT and 12& 13 are samples
infected with M. smegmatisT. ACTB primer set was used for amplification.
RNA samples                                      - +                       
Stellenbosch University  http://scholar.sun.ac.za
36 
 
 In order to assess the purity of the extracted RNA, the agarose gel was visualised under UV 
light (see section 2.5.1 for details). As expected, a band was observed for the positive control 
and not for the negative control or the RNA samples (Figure 3.4), since PCR amplifies DNA 
only. These results indicate that the PCR reagents and the extracted RNA were free of gDNA 
contamination. 
 
  3.1.2.2 Assessment of RNA integrity and quantity using the  
Agilent 2100 Bioanalyzer 
 
 
The Agilent 2100 Bioanalyzer is an automated gel electrophoresis system that was used to 
calculate the integrity of RNA to give a quantitative measure of the RNA quality (Nolan et 
al., 2006). The virtual gel generated from the Bioanalyzer system illustrates the intensity and 
the size of the 28S and 18S rRNA bands and is used to assess the integrity of the RNA 
(Figure 3.5). The size and the intensity of the 28S bands were detected to be double that of 
the 18S bands, indicating intact RNA. In order to verify the calculated integrity of the RNA, a 
28S
18S
Figure 3.5 Virtual gel generated by the Agilent Bioanalyzer 2100, illustrating the
Integrity of the extracted total RNA. This image is a representative example of the
quality of all the RNA samples. RNA was extracted from the infected and uninfected
cells (control) at 3 h, 24 h and 48 h post infection with M. tb. C= uninfected, NT=
samples infected with M. tbNT and T= samples infected with M. tbT.
Stellenbosch University  http://scholar.sun.ac.za
37 
 
28S/18S ratio, as well as the RIN value (Table 3.1) was used. The RIN value is considered to 
be more accurate for the evaluation of RNA integrity as compared to the 28S/18S ratio 
(Nolan et al., 2006). All the RIN values were above 9.5, confirming intact RNA; even though 
























Table 3.1 Summary of the results generated by the Agilent 
2100 Bioanalyzer. This data is from one of the experiments 
conducted and it is a representative example of all the RIN 
values, 28S/18S ratios and RNA concentration of extracted RNA. 
Samples 1-6 represent M. tb experiment and 7-12 represent M. 
smegmatis experiment. The experiments were conducted in 
technical duplicates. Samples 1, 2, 7 and 8 are controls; samples 
3, 4, 9 and 10 are infected with mycobacteria
NT
 and samples 5, 6, 
11 and 12 are infected with mycobacteria
T
. 
Sample Conc. (ng/µl) 28S/18S ratio RIN 
1 753 1.8 9.7 
2 789 1.9 9.7 
3 778 1.8 9.7 
4 599 1.7 9.6 
5 901 1.8 9.6 
6 795 1.8 9.7 
7 599 2.0 9.7 
8 984 1.8 9.6 
9 1 000 1.8 9.6 
10 492 1.5 9.7 
11 511 1.6 9.7 
12 1 344 1.8 9.6 
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3.1.3 Gene expression analysis 
The 12 genes (Table 2.1) that were assessed were selected based on their roles in the 
phagocytic pathway and autophagy (section1.6), since these pathways are central to M. tb 
infection. qRT-PCR was performed to determine the differential expression levels of the 
selected genes in response to M. tb, M. bovis BCG and M. smegmatis, cultured with and 
without Tween 80. Statistically significant (p-values ≤ 0.05) differential gene expression was 




Gene expression was measured at different time periods during infection, in order to 
determine whether the trends of expression were maintained over the infection period. The 
expression was measured at 3 h, 24 h and 48 h from M. tb- and M. bovis BCG-infected 
dTHP-1 cells and at 3 h and 8 h in M. smegmatis- infected dTHP-1 cells; relative to the 
uninfected cells across the same time points. The 24 h was included because it is a common 
time point reported in macrophage infection studies (Delgado et al., 2008; Herbst et al., 2011; 
McGarvey et al., 2004; Simeone et al., 2012). The 3 h and the 48 h time points were included 
to assess the early and the late response of the dTHP-1 cells, respectively. The 3 h time 
period for M. smegmatis-infected dTHP-1 cells was used to assess the early response. The 8 h 
time point instead of the 24 h and 48 h was selected to assess the late response of M. 
smegmatis-infected dTHP-1 cells. Since M. smegmatis is a fast grower, the problem of 
extracellular growth was observed at time periods later than 8 h infection, while M. 
































The M. tb results are illustrated in Figure 3.6 and summarised (Fold changes and p-values) in 
Table 3.2. Following 3 h infection with M. tb
NT
, IL-10, CCL1 and IL-12 were significantly 
upregulated and VAMP7, TLR7 and YWAH were downregulated. During the same time 
period in response to M. tb
T
, TLR9, IL-10, STX4 and VAMP7 were downregulated; while  
TLR7, CLIC4 and PRKCA were upregulated. A significant downregulation of STX7, TLR7, 
CLIC4, YWAH, IL-12 and upregulation of IL-10 were observed 24 h post infection with M. 
tb
T
, while upregulation of CCL1 and downregulation of STX7, TLR9, TLR7 and IL-12 were 
observed for M. tb
NT
 infection. In response to 48 h infection; STX7, CLIC4 and PRKCA 
were significantly upregulated by M. tb
T
 and PRKCA and CCL1 were upregulated by M. 
tb
NT





















































Figure 3.6 Gene expression of dTHP-1 cells in response to M. tb infection. A. Infection with 
M. tb
T
. B. Infection with M. tb
NT
. The inserted graph Figure B (II) depicts the two genes (CCL1 
and IL-12β) that were highly expressed by M. tb
NT
 in all 3 time periods. CCL1 and IL-12β were 
excluded from Figure B (I) due to their large fold changes and for better visual display of the fold 
changes of the 9 other genes. The upregulation and downregulation of the target genes was 
measured relative to the uninfected controls, using the randomised pair wise statistical test of the 
REST programme. See Table 3.2 for statistical significant results. 
 
























The M. smegmatis results are illustrated in Figure 3.7 and summarised (Fold changes and p-
values) in Table 3.3. IL-10, TLR7, CCL1 and IL-12 were significantly upregulated by both 
M. smegmatis
T
 and M. smegmatis
NT
 3 h post-infection, TLR9 was upregulated by M. 
smegmatis
T 
and VAMP7 and CLIC4 by M. smegmatis
NT
. During the 8 h time period TLR9, 

















































 B (II) 
3h
Figure 3.7 Gene expression of dTHP-1 cells in response to M. smegmatis infection. A. Infection with 
M. smeg
T
. B. Infection with M. smeg
NT
. The inserted graph, Figure B (II) depicts the two genes (IL-10 
and IL-12β) that were highly expressed by M. tb
NT
 at 3h time period. The 3h time point of IL-10 and IL-
12β was excluded from Figure B (I) due to their large fold changes and for better visual display of the 
fold changes of the 9 other genes. The upregulation and downregulation of the target genes was 
measured relative to the uninfected controls, using the randomised pair wise statistical test of the REST 
programme. See Table 3.3 for statistical significant results. 
 























The M. bovis BCG results are illustrated in Figure 3.8 and summarised (Fold changes and p-
values) in Table 3.4. In response to 3h infection with M. bovis BCG, STX7 and TLR9 were 
significantly downregulated by M. bovis BCG
T
 while IL-10, CLIC4 and IL-12 were 
upregulated. In contrast, STX7 and TLR9 were upregulated by M. bovis BCG
NT
 while IL-10, 
CLIC4 and IL-12 were downregulated. In addition, VAMP7 was upregulated by both M. 
bovis BCG
T
 and M. bovis BCG
NT
, while STX4 and CCL1 were upregulated by only M. bovis 
BCG
T 
and PRKCA by M. bovis BCG
NT
. Furthermore, GANC and TLR7 were downregulated 
by M. bovis BCG
T
 and M. bovis BCG
NT
































Figure 3.8 Gene expression of dTHP-1 cells in response to BCG infection. A. Infection with BCG
T
 B. Infection 
with BCG
NT
. The inserted graph (Figure B (II)) depicts the three genes (IL-10, CCL1 and IL-12β) that were 
highly expressed by M. tb
NT
 at 3h, 24h and 48h time periods. IL-10, CCL1 and IL-12β were excluded from 
Figure B (I) due to their large fold changes and for better visual display of the fold change of the 8 other 
genes. The upregulation and downregulation of the target genes was measured relative to the uninfected 






















 for 24 h IL-10 was downregulated, while STX4 and VAMP7 were 
upregulated. When infected with M. bovis BCG
NT 
for the same time period CCL1 was 
upregulated. CCL1 and PRKCA were significantly upregulated in response to both M. bovis 
BCG
T
 and M. bovis BCG
NT
 48 h post infection and STX4 was upregulated by M. bovis 
BCG
T
 but downregulated by M. bovis BCG
NT
. In addition, TLR9, TLR7 and VAMP7 were 
significantly upregulated by M. bovis BCG
T
, whereas IL-10, YWAH and IL-12β were 











































































Figure 3.9 Differential expression of dTHP-1 cells infected with pathogenic and non-pathogenic 
mycobacteria. TLR7 (A) and VAMP7 (B) showed difference in expression by M. tb
NT
 and M. smegmatis
NT
. 
The upregulation and downregulation of the target genes was measured relative to the uninfected 
controls, using the randomised pair wise statistical test of the  REST programme. Statistical significant (p-
values ≤ 0.05) results are indicated by red stars and the black star indicates a p-value close to 0.05 (0.008). 
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Of the 12 genes that were studied, a significant differential expression in response to M. tb 
and M. smegmatis was detected for TLR7 and VAMP7 (Figure 3.9). dTHP-1 cells exhibited a 
consistent downregulation of TLR7 and VAMP7 when infected with M. tb
NT
 and 
upregulation when infected with M. smegmatis
NT
 during all time periods. However, the 24 h 
expression of VAMP7 and the 48 h expression of TLR7 were not significantly different (p-
values of 0.547 and 0.064, respectively) (Tables 3.2 and 3.3). In response to BCG
NT
 
infection, there was no consistent trend of expression detected for VAMP7 or TLR7; 
however, a significant upregulation of VAMP7 in response to BCG
T 
was observed at all 3 
time periods (Table 3.4). Results illustrated in Figure 3.9 and summarised (Fold changes and 














































Figure 3.10 Differential expression of CCL1 in response to Mycobacteria cultured with and without 
Tween 80. A. CCL1 response to M. tb infection. B. CCL1 response M. smegmatis infection. C. CCL1 
response to BCG infection. The significant difference in CCL1 expression levels in response to infection 
with mycobacteria
T/ NT 
suggests that the presence of Tween 80 in the culture medium of mycobacteria 
seems to inhibit the expression of CCL1. The upregulation and downregulation of the target genes was 
measured relative to the uninfected controls, using the randomised pair wise statistical test of the  REST 
programme. Red stars indicate statistically significant results (p-value ≤ 0.05) and the black star indicates 
p-value close to 0.05 (0.074). 
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CCL1 showed a similar expression trend in response to M. tb, M. bovis BCG and M. 
smegmatis infections. This gene was upregulated in response to all 3 strains, cultured with or 
without Tween 80. Furthermore, the expression of CCL1 was significantly higher in response 
to mycobacteria
NT
 as compared to mycobacteria
T
. Results are illustrated in Figure 3.10 and 
summarised (Fold changes and p-values) in Tables 3.2-3.4. 
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Table 3.2 Summary of results generated by the REST programme for M. tb infection. Differential gene expression of dTHP-1 cells in 




 3h 24h 48h 














STX7 -3.52 0.073 -1.70 0.074 -1.92 0.001 -2.00 0.024 13.47 0.001 1.30 0.368 
TLR9 -6.15 0.01 1.41 0.682 -1.01 0.979 -8.78 0.011 -2.91 0.46 1.64 0.437 
GANC -2.11 0.083 -1.61 0.252 1.13 0.767 1.24 0.761 1.28 0.915 -1.26 0.726 
IL-10 -15.76 0.001 2.83 0.027 1.94 0.001 1.69 0.311 -1.10 0.978 -1.73 0.533 
STX4 -3.77 0.014 -1.05 0.951 -1.82 0.111 -1.48 0.57 3.17 0.16 -1.07 0.91 
TLR7 3.32 0.02 -2.80 0.041 -6.49 0.001 -2.53 0.015 1.39 1 -2.60 0.064 
CCL1 -8.00 0.006 11.43 0.001 1.48 0.483 11.13 0.028 2.81 0.385 21.48 0.001 
VAMP7 -10.41 0.025 -2.51 0.032 1.25 0.98 -1.44 0.547 1.87 0.996 -2.17 0.008 
CLIC4 6.82 0.001 1.14 0.835 -10.11 0.001 -1.64 0.466 7.70 0.001 -5.83 0.001 
PRKCA 1.61 0.001 -1.34 0.154 2.29 0.102 -1.37 0.987 3.90 0.005 2.31 0.02 
YWAH -1.60 0.215 -2.74 0.001 -2.71 0.001 -1.51 0.465 1.15 1 -1.05 0.9 
IL-12 -1.82 0.233 66.95 0.001 -16.74 0.001 -66.03 0.001 1.08 1 -1.95 0.101 
T = Cultured with Tween 80, NT = Cultured without Tween 80, p-values highlighted in red represent a significant response 
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Table 3.3 Summary of results generated by the REST programme for M. smegmatis 
T/NT
 





 3h 8h 










STX7 1.72 0.161 1.42 0.563 -1.37 0.354 1.04 0.917 
TLR9 2.82 0.001 1.47 0.457 3.88 0.001 4.88 0.001 
GANC -1.11 0.938 1.50 0.488 1.05 0.549 -1.40 0.208 
IL-10 3.62 0.001 54.22 0.001 3.86 0.001 4.42 0.003 
STX4 1.35 0.841 1.09 0.998 -1.28 0.496 1.02 1 
TLR7 2.63 0.019 3.78 0.001 1.05 0.914 1.86 0.014 
CCL1 3.32 0.001 10.03 0.001 2.72 0.001 8.17 0.001 
VAMP7 1.82 0.101 2.32 0.017 3.07 0.001 2.05 0.001 
CLIC4 1.37 0.75 2.45 0.001 1.23 0.608 1.25 0.843 
PRKCA -1.11 0.987 -1.06 0.995 -1.41 0.272 -1.42 0.364 
YWAH 1.68 0.204 1.36 0.695 1.95 0.001 1.74 0.012 
IL-12β 3.13 0.001 101.83 0.001 -1.20 0.473 5.06 0.001 
T = Cultured with Tween 80, NT = Cultured without Tween 80, p-values highlighted in red represent 
  a significant response 
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Table 3.4 Summary of results generated by the REST programme for M. bovis BCG. Differential gene expression of dTHP-1 cells in 
response to 3h, 24h and 48h infection with M. bovis BCG
T/NT
. 
M. bovis BCG 
 3h 24h 48h 














STX7 -1.14 0.001 2.12 0.001 -1.12 0.899 1.55 0.746 -1.53 0.289 1.19 0.339 
TLR9 -1.55 0.026 4.26 0.001 1.51 0.297 1.01 1 2.42 0.018 1.49 0.218 
GANC -1.23 0.03 1.32 0.103 1.07 0.981 1.15 0.992 1.44 0.291 1.51 0.071 
IL-10 3.22 0.001 -19.56 0.001 -1.34 0.001 -2.97 0.128 -2.00 0.068 2.54 0.044 
STX4 1.36 0.015 -1.15 0.201 2.37 0.008 -1.77 0.444 2.17 0.019 -1.76 0.012 
TLR7 -1.08 0.537 -1.30 0.018 1.47 0.353 -1.16 0.968 5.36 0.001 1.42 0.074 
CCL1 2.03 0.001 1.85 0.074 1.39 0.47 10.13 0.001 8.82 0.001 53.38 0.001 
VAMP7 1.44 0.004 1.68 0.001 2.20 0.001 -1.12 0.968 3.07 0.001 -1.24 0.323 
CLIC4 1.15 0.044 -1.41 0.03 1.38 0.431 1.28 0.995 1.37 0.353 1.25 0.187 
PRKCA 1.26 0.245 1.35 0.001 1.40 0.133 1.44 0.863 1.52 0.034 2.47 0.001 
YWAH 1.00 0.959 1.03 0.893 1.53 0.214 -1.14 0.979 1.40 0.38 1.89 0.003 
IL-12 5.52 0.001 -30.20 0.001 -1.41 0.414 -1.28 0.822 1.22 0.671 3.31 0.001 
T = Cultured with Tween 80, NT = Cultured without Tween 80, p-values highlighted in red represent a significant response 
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The current anti-TB drugs have had success in decreasing the deaths caused by TB (WHO, 
2013), however this success has been compromised by the emergence of drug resistant strains 
(Fakruddin, 2013; Merza et al., 2011; Wang et al., 2006). The mechanism of action of the 
anti-TB drugs (target mycobacterial enzymes and pathways) is a major contributing factor to 
drug resistance (De La Iglesia and Morbidoni, 2006; Mdluli and Ma, 2007; Timmins and 
Deretic, 2006; Walsh, 2000). A different approach involves developing drugs that will target 
host enzymes, rather than mycbacterial enzymes (Jayaswal et al., 2010; Schwegmann and 
Brombacher, 2008) and it requires knowledge of the host factors that affect the intracellular 
survival of the pathogen (Huang et al., 2010; Jayaswal et al., 2010; Li et al., 2006). 
Therefore, this study focused on identification of genes of dTHP-1 cells that are differentially 
expressed by different mycobacterial species  
 
A subset of 12 eukaryotic genes was selected for this study based on their known 
involvement in the phagocytic pathway and autophagy, as well as for their roles in immune 
response, in general (see section 1.6). Of these, VAMP7 and TLR7 were significantly 
differentially expressed by mycobacteria
NT
, but not by mycobacteria
T
. Therefore, only their 
responses to mycobacteria
NT
 will be discussed. Additionally, CCL1 was highly expressed by 
mycobacteria
NT
 as compared to mycobacteria
T 
and will also be discussed further. 
 
3.2.1. Generation of single cell from mycobacteria
NT 
Several studies have emphasized the drawbacks of using Tween 80 as a supplement in 
mycobacterial cultures. Although it is essential in minimizing clumps, it has been identified 
to have adverse effects on the mycobacterial cell wall integrity, solubilising the capsule that 
is implicated in mycobacterial virulence (Sani et al., 2010; Van Boxtel et al., 1990; Wang et 
al., 2010). In order for an in vitro interaction to mimic the in vivo state, it is important that the 
mycobacteria are as close to their native state as possible. This has raised concern about 
whether the effect of Tween 80 on the mycobacterial cell wall interferes with the interaction 
of mycobacteria with macrophages. It is for this reason we decided to culture the 3 
mycobacterial species in growth medium
NT 
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We observed that about 90% of mycobacteria cultured in growth medium
NT
 were present in 
clumps. Additionally, the older (high OD600) the cultures got the more clumps were formed. 
We observed that beyond the OD600 of 0.3 more mycobacteria were present in clumps than in 
single form, and there were almost no mycobacteria present in the culture medium (explained 
by the clear colour of the culture medium and mycobacterial precipitates at the bottom of the 
50 ml tubes, as well as the very low (close to Zero) OD600 readings. Since the cultures grown 
to an OD600 of 0.3 exhibited some (about 10%) mycobacteria cells present in single form 
(assessed by ZN slides under oil immersion, section 2.1.4.1), we therefore decided to culture 
mycobacteria
NT
 to a lower OD600 of 0.3, in order to increase the probability of generating 
mycobacterial cultures with cells present in a single form.   
 
Although the frozen mycobacterial
NT
 stocks were syringed twice with a 25G needle (our 
standard lab protocol used to break up mycobacterial clumps) during processing for infection, 
we still observed the same amount of clumps following syringing. The elimination of the 
clumps was achieved through filtration process using the 5 µm pore filter (as described in 
section 2.3.2), adapted from (Sani et al., 2010). The 5 µm pores of the filter were big enough 
to allow single bacteria and small clumps (containing 2-3 bacteria) to pass through without 
compromising cell viability (assessed by CFUs). Even though most of the mycobacteria
NT
 
were lost after filtration, we managed to generate single form mycobacterial suspension for 
infection, limiting the probability of mycobacterial phagosomes to be trafficked to lysosomes 
due to clumps. 
 
3.2.2 Effect of Tween 80 on the mycobacterial cell wall affects gene  
expression in dTHP-1 cells 







wherein the expression of CCL1, a chemokine involved 
in the formation of granulomas (Tal et al., 2007), was more expressed in response to 
mycobacteria
NT
 compared to mycobacteria
T
. The lowered expression of CCL1 due to the 
presence of Tween 80 in mycobacteria cultures indicates that the perturbations of Tween 80 
on mycobacterial cell wall potentially affect the interaction of mycobacteria with 
macrophages. This data suggest that a high throughput screening method is warranted to 
analyse the global changes induced by mycobacteria
T
. Consistent with our results, Thuong et 
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al (2008) demonstrated that CCL1 was upregulated by M. tb; additionally, they identified 6 
SNPs near CCL1 that were associated with pulmonary TB (Thuong et al., 2008). 
Furthermore, CCL1 was reported to be upregulated in granulomas induced by M. bovis 
purified protein derivative (PPD) (Chiu et al., 2003; Hoshino et al., 2007).  
 
In the present study it was observed that CCL1 was upregulated by both M. tb and M. 
smegmatis strains cultured with and without Tween 80. The upregulation of CCL1 leads to 
granuloma formation, which primarily acts to prevent the spread of infection (Hoshino et al., 
2007; Thuong et al., 2008). However, M. tb is able to survive in a dormant state inside the 
granuloma and later reactivate and escape the granuloma to subsequently spread to the rest of 
the body and progress to active TB disease (Silva Miranda et al., 2012). Therefore, the 
upregulation of CCL1 upon infection with M. tb does not guarantee control of M. tb spread, 
since it can escape the granulomas. Although CCL1 was also upregulated by M. smegmatis, 
this response may not be important since M. smegmatis is killed inside macrophages (Anes et 
al., 2006); hence the infection does not progress to the point of granuloma formation.  
 
3.2.3 Effect of different times of exposure on gene expression of  
mycobacteria
NT
- infected dTHP-1 cells 
M. tb and M. bovis BCG are distinctly characterised from M. smegmatis by their ability to 
survive inside macrophages (Anes et al., 2006; McDonough et al., 1993; McGarvey et al., 
2004; Walburger et al., 2004) and this ability is associated with M. tb pathogenicity 
(McGarvey et al., 2004; Schlesinger, 1996). It is worth mentioning that the classification of 
BCG pathogenicity remains ambiguous. However, it is regarded as non-pathogenic due to the 
absence of the RD1 region that was found to be conserved in all pathogenic mycobacteria 
(Lewis et al., 2003; Majlessi et al., 2005; Simeone et al., 2012). Even though these  
mycobacteria species can tolerate microbicidal activities of macrophages, under certain 
conditions they can be killed (Cross et al., 1999; Herbst et al., 2011) and the killing 
mechanisms are poorly understood; however,  phagosome/ endosome-lysosome fusion and 
autophagy are implicated (Anes et al., 2006; Gutierrez et al., 2004). 
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VAMP7 is a transmembrane protein predominantly found in late endosomes and it is 
involved in the transport and fusion of late endosomes with lysosomes for subsequent 
degradation of invading pathogens (Advani et al., 1999). Moreover, VAMP-7 has been 
indicated to play a role in the phagocytic pathway (Braun et al., 2004), however, no other 
studies (to our knowledge) are available to support this. TLR7 is predominantly expressed in 
lung macrophages (Delgado et al., 2008), which are primary cells of pulmonary M. tb 
infection (Reljic et al., 2010). The ligands of TLR7, especially imiquimod induce autophagy 
in macrophages (De Meyer et al., 2012; Delgado et al., 2008).  
 
We observed that the infection of macrophages with M. tb
NT
 resulted in suppression of 
VAMP7 and TLR7 expression and this response was maintained over the infection period 
(defined by the constant fold changes observed throughout the time periods). Since both 
genes induce protective effects against invading pathogens (Advani et al., 1999; De Meyer et 
al., 2012; Delgado et al., 2008), their downregulation by M. tb concurs with the ability of M. 
tb to withstand the hostile environment of macrophages (Walburger et al., 2004). Hence; M. 
tb most likely suppressed the expression of these genes as a defence mechanism to avoid 
induction of endosome-lysosome fusion and autophagy, thereby promoting its intracellular 
survival. A similar observation at 24 h and 48 h was seen in an in vivo study by (Avunje et 
al., 2013, 2011) in which VHSV (Viral haemorrhagic septicaemis virus) infection caused 
suppression of TLR7 in Olive flounder reared at 15 °C (Avunje et al., 2013, 2011). 
 
In contrast to M. tb and M. bovis BCG, the infection with M. smegmatis
NT
 led to induction of 
these genes, which was expected since M. smegmatis is killed inside macrophages (Anes et 
al., 2006). A pronounced decrease with time was observed for TLR7 (whereas the response 
of VAMP7 remained constant), wherein the 3 h infection period exhibited a two-fold higher 
expression than the 8 h. This difference could be attributed to the fact that TLR7 is a surface 
receptor (Delgado et al., 2008), and therefore may be more induced during the uptake of the 
bacteria (3 h) than downstream during the intracellular killing or survival of the mycobacteria 
(8 h).  This explanation is supported by the general role of PRRs, which is to protect the host 
during early infection (Schiller et al., 2006) through recognition of invading pathogens and 
activation of innate immunity for subsequent elimination of the intracellular pathogens (De 
Meyer et al., 2012; Delgado et al., 2008). 
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3.2.4 Effect of different mycobacterial strains on macrophage gene expression 
M. tb elicits greater resistance to the acidic macrophage environment as compared to BCG 
(McDonough et al., 1993; Simeone et al., 2012). This was evident at 3 h post-infection, in 
which a greater degree of suppression of TLR7 and VAMP7 expression by M. tb
NT
 was 
observed when compared to M. bovis BCG
NT
. These results may potentially relate to the fact 
that M. bovis BCG has a relatively lower survival rate in macrophages (McDonough et al., 
1993).  
 
3.2.5 Potential therapeutic applications of TLR7 and VAMP7 
Therapeutic applications relavant to this study results include targeting TLR7 and VAMP7 
via RNA activation (RNAa). RNAa is a newly discovered phenomena that uses synthetic 
small double-stranded RNAs (dsRNAs), termed small activating RNAs (saRNAs) to induce 
sequence-specific gene expression activation by targeting  specific regions in the gene 
promoter (Huang et al., 2010; Janowski et al., 2007; Li et al., 2006; Place et al., 2008). If the 
activation of TLR7 and VAMP7 by synthetic saRNAs in M. tb-infected macrophages lead to 
decreased growth of M. tb intracellularly, this may suggest that these 2 genes are feasible 
targets for RNAa-based TB therapeutics. 
 
The therapeutic feasibility of the RNAa approach has been demonstrated by several studies. 
Yang et al (2013) have successfully demonstrated that the saRNA-induced activation of 
PAWR gene, a cancer-selective target for cancer therapies, that is essential for apoptosis and 
for suppressing tumours, induces the growth inhibition and apoptosis of cancer cells. These 
findings suggested potential of PAWR as target gene in cancer therapy (Yang et al., 2013). 
Additionally, Li et al. (2006) verified the role of small ds-RNAs in activating gene expression 
and further identified their potential use in gene activation-based therapies (Li et al., 2006). 
 
A further approach to anti-TB drug development research may include application of RNA 
interference (RNAi). The cellular process in which gene expression can be silenced 
transcriptionally by targeting the specific region in the gene promoter or post-transcription 
via cleavage and degradation of mRNA, using small interfering RNAs (siRNAs) (Bumcrot et 
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al., 2006; Burnett and Rossi, 2012; Pal-Bhadra et al., 2002; Sijen et al., 2001). However, this 
approach will be feasible for genes that are upregulated by M. tb (Jayaswal et al., 2010). 
Since the current approach to drug development is challenged due to the emergence of drug 
resistant strains, RNA-based therapeutics (RNAa and RNAi) could be a solution to replace 
the drugs that are currently failing, based on their advantage to potentially limit drug 
resistance, since host enzymes are the direct targets (Jayaswal et al., 2010; König et al., 2008; 
Li et al., 2006). However, there are potential challenges such as optimazation of selectivity, 
stability, delivery and long term safety that will need to be closely considered. Although 
RNA-based therapeutics is still in its infancy, there is accumulating evidence supporting their 























This study has successfully generated single cells from mycobacteria
NT
 during processing for 
infection, using the filtration method (as described in section 2.3.1, 2.3.2) without 
compromising the viability of the cells (assessed by CFUs). According to our knowledge this 
is the first study in which mycobacteria was successfully cultured without chemical (Tween 
80) and/or mechanical (agitation) perturbations and was still able to generate single cells for 
infection.  
 
Both VAMP 7 and TLR 7 were downregulated by M. tb
NT
 and upregulated by M. 
smegmatis
NT
. This differential gene expression induced by the pathogenic and non-
pathogenic mycobacterial species suggest that these genes may be feasible to target via 
RNAa, in order to determine if their induction will result in decreased growth of intracellular 
mycobacteria. Since the results of BCG were not statistically significant at 24 h and 48 h 
(Table 3.4), we could not distinguish if the response of these genes was specific to 
macrophages. However, the M. tb and M. smegmatis results suggest that these genes may be 
potential targets for RNA-based TB-therapeutics  
 
The consistent significant differential expression of TLR7 and VAMP7 was induced by 
mycobacteria
NT
 but not by mycobacteria
T
, suggesting that the perturbations caused by Tween 
80 on the mycobacterial cell wall might have altered the transcriptional response of 
macrophages  
 
CCL1 was the only gene that showed difference in gene expression in relation to culturing 
mycobacteria with and without Tween 80. It expression was stronger in response to 
mycobacteria
NT
 when compared to mycobacteria
T
. This is proof of concept that the 
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perturbations caused by Tween 80 in the mycobacterial cell wall potentially altered the 
macrophage response to mycobacterial infection. Furthermore, these findings are in 
accordance with the studies (Sani et al., 2010; Van Boxtel et al., 1990) that have emphasized 
the need for Tween 80 exclusion in mycobacterial cultures.  
 
Despite all the statistically significant gene expression induced by mycobacteria
T
, none of the 
genes showed consistent differential expression between pathogenic and non-pathogenic 




For future studies, given the results obtained for CCL1, a follow up study using a high 
throughput screening method such as RNA sequencing, is necessary in order to determine the 
global changes in gene expression, in relation to the effect of Tween 80. In addition, it is 
necessary that Tween 80 be excluded from culture media for all mycobacterial species. In 
case of comparison studies, all mycobacterial species (cultured in the presence or absence of 
Tween 80) should be grown to the same. Since it was observed that the cultures became 
excessively clumpy beyond OD600 of 0.3, this OD was chosen as a feasible cut off.  
Furthermore, more and later time points should be included, in order to study the macrophage 
response at later stages of mycobacterial infection and to verify if the response will be 
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